{"id":"NCT04176939","sponsor":"GlaxoSmithKline","briefTitle":"A Study to Test GlaxoSmithKline's (GSK) Herpes Zoster (HZ) Subunit Vaccine's Long-term Immune Response in Previously Vaccinated Kidney Transplant Adults and Then to Test if 2 Additional Doses of the Vaccine Are Safe and Able to Generate an Immune Response","officialTitle":"Long-term Immunogenicity Study of Herpes Zoster Subunit Vaccine (GSK1437173A) and Immunogenicity and Safety Assessment of Revaccination With Two Additional Doses in Adults With Renal Transplant From Study ZOSTER-041","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-12-09","primaryCompletion":"2022-08-12","completion":"2024-06-27","firstPosted":"2019-11-25","resultsPosted":"2023-12-20","lastUpdate":"2025-07-18"},"enrollment":68,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Herpes Zoster"],"interventions":[{"type":"BIOLOGICAL","name":"HZ/su vaccine (GSK1437173A)","otherNames":[]}],"arms":[{"label":"HZ/su Group","type":"EXPERIMENTAL"}],"summary":"The purpose of this study was to evaluate the long-term immune responses to the Herpes Zoster subunit (HZ/su) vaccine as well as safety up to 7 years after the 2-dose primary vaccination course from study ZOSTER-041 (NCT02058589). This study also assessed immune responses as well as safety after revaccination with 2 additional doses of the HZ/su administered at 6 to 8 years after the 2-dose primary vaccination course.","primaryOutcome":{"measure":"Anti-glycoprotein E (Anti-gE) Antibody Concentrations, as Assessed in the Long Term Follow-up (LTFU) Phase of the Current ZOSTER-073 Study","timeFrame":"At Day 1, Month 12 and Month 24 (pre-revaccination) in the current ZOSTER-073 study","effectByArm":[{"arm":"HZ/su Group","deltaMin":3729.8,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":null},"locations":{"siteCount":15,"countries":["Belgium","Canada","Finland","Panama","South Korea","Spain","Taiwan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":23,"n":68},"commonTop":["Administration site pain","Fatigue","Headache","Myalgia","Chills"]}}